John Bartlett

Cited by

	All	Since 2016
Citations	46829	28558
h-index	87	58
i10-index	301	204

7000

3500

1750

5250

200120022003200420052006200720082009201020112012201320142015201620172018201920202021131 189 222 304 441 514 670 1005 1113 1448 1593 1875 2153 2388 2816 3296 3508 3984 5199 6370 6118

Public access

View all

90 articles

8 articles

available

not available

Based on funding mandates

Co-authors

Giuseppe VialeUniversità di Milano e Istituto Europeo di OncologiaVerified email at ieo.it
Christos Markopoulos, Professor of Su...National and Kapodistrian University of Athens, Medical School, Athens, GreeceVerified email at med.uoa.gr
Going, James J.Consultant Histopathologist, GlasgowVerified email at udcf.gla.ac.uk
Hein PutterProfessor of Medical Statistics, Leiden University Medical CenterVerified email at lumc.nl
Caroline J Witton WarnerResearch Scientist, AgilentVerified email at agilent.com
Antonio C. Wolff, MD, FACP, FASCOProfessor of Oncology, Johns Hopkins UniversityVerified email at jhmi.edu
Torsten NielsenProfessor of Pathology, University of British ColumbiaVerified email at mail.ubc.ca
Tove KirkegaardKirurgisk Afdeling, Køge og Roskilde Sygehus, ForskningskoordinatorVerified email at tovekirkegaard.dk
Peter S HallUniversity of EdinburghVerified email at ed.ac.uk
David G. HicksProfessor of Pathology and Laboratory MedicineVerified email at urmc.rochester.edu
Kathleen I. PritchardProfessor, Division of Medical Oncology, University of TorontoVerified email at sunnybrook.ca
Christopher McCabeExecutive Director and CEO, Institute of Health Economics, AlbertaVerified email at ualberta.ca
Fatima CardosoBreast Unit, Champalimaud Clinical Center, Lisbon, PortugalVerified email at fundacaochampalimaud.pt
Simon LangdonUniversity of Edinburgh, ReaderVerified email at ed.ac.uk
Judith BlissProfessor of Clinical Trials, The Institute of Cancer ResearchVerified email at icr.ac.uk
Christos SotiriouUniversité Libre de BruxellesVerified email at bordet.be
Emad RakhaUniversity of NottinghamVerified email at nottingham.ac.uk
Liane McGlynnUniversity of Glasgow, Institute of Cancer SciencesVerified email at glasgow.ac.uk
Andrew H SimsUniversity of EdinburghVerified email at ed.ac.uk
Paul PharoahUniversity of CambridgeVerified email at medschl.cam.ac.uk

John Bartlett

Director of Transformative Pathology, Ontario Institute for Cancer Research

Verified email at oicr.on.ca - Homepage

Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Human epidermal growth factor receptor 2 testing in breast cancer AC Wolff, M Hammond, KH Allison, BE Harvey, PB Mangu, J Bartlett, ...	5172	2007
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice … AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ... Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2014	4067	2014
Comprehensive molecular characterization of gastric adenocarcinoma AJ Bass, V Thorsson, I Shmulevich, SM Reynolds, M Miller, B Bernard, ... Nature 513 (7517), 202, 2014	3263	2014
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015	1694	2015
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018	1667	2018
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ... Journal of the National cancer Institute 103 (22), 1656-1664, 2011	1609	2011
Comprehensive molecular characterization of muscle-invasive bladder cancer AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ... Cell 171 (3), 540-556. e25, 2017	1227	2017
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018	1208	2018
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ... Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018	895	2018
Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017	852	2017
Integrated genomic characterization of endometrial carcinoma G Getz, SB Gabriel, K Cibulskis, E Lander, A Sivachenko, C Sougnez, ... Nature Publishing Group, 2013	829	2013
A short history of the polymerase chain reaction JMS Bartlett, D Stirling PCR protocols, 3-6, 2003	779	2003
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003	672	2003
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press Journal of Clinical Oncology 27 (8), 1323-1333, 2009	579	2009
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of oncology 25 (8), 1536-1543, 2014	547	2014
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ... Annals of Oncology 25 (8), 1536-1543, 2014	547	2014
An international Ki67 reproducibility study MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ... Journal of the National Cancer Institute 105 (24), 1897-1906, 2013	511	2013
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer J Edwards, NS Krishna, KM Grigor, JMS Bartlett British journal of cancer 89 (3), 552-556, 2003	438	2003
Multidisciplinary meeting on male breast cancer: summary and research recommendations LA Korde, JA Zujewski, L Kamin, S Giordano, S Domchek, WF Anderson, ... Journal of Clinical Oncology 28 (12), 2114, 2010	437	2010
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial CJH Van de Velde, D Rea, C Seynaeve, H Putter, A Hasenburg, ... The Lancet 377 (9762), 321-331, 2011	416	2011

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow this author

Cited by

Co-authors